In conclusion, we found that WZ35 synergized the anti-tumor effect of cisplatin by inhibiting TrxR1 activity, and demonstrated that the combined treatment induced apoptotic cell death through ROS-mediated p38 and JNK signaling pathways. This evidence concerns the gene TXNRD1 and neoplasm.